scholarly journals Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia

2016 ◽  
Vol 17 ◽  
pp. 235-240
Author(s):  
Yuhei Nojima ◽  
Madoka Ihara ◽  
Tetsuya Kurimoto ◽  
Shinsuke Nanto
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Light Chain ◽  
Immunoglobulin E ◽  
Preserved Ejection Fraction ◽  
Light Chain Amyloidosis ◽  
Amyloid Light Chain

scholarly journals STRAIN IMAGING IN LIGHT-CHAIN AMYLOIDOSIS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION

2018 ◽  
Vol 71 (11) ◽  
pp. A887
Author(s):  
Sergio Barros-Gomes ◽  
Fletcher Miller ◽  
Patricia Pellikka ◽  
Angela Dispenzieri ◽  
Hector Villarraga
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Light Chain ◽  
Strain Imaging ◽  
Preserved Ejection Fraction ◽  
Light Chain Amyloidosis

scholarly journals Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma

2017 ◽  
Vol 18 ◽  
pp. 790-793
Author(s):  
Edgar Francisco Carrizales-Sepúlveda ◽  
Alejandro Ordáz-Farías ◽  
Raymundo Vera-Pineda ◽  
Mario Alberto Benavides-González ◽  
Ramiro Flores-Ramírez
Keyword(s):  
Heart Failure ◽  
Multiple Myeloma ◽  
Congestive Heart Failure ◽  
Ejection Fraction ◽  
Light Chain ◽  
Al Amyloidosis ◽  
Preserved Ejection Fraction

Acute heart failure with preserved ejection fraction and long-term Readmisions

2008 ◽  
Vol 7 ◽  
pp. 62-63
Author(s):  
J NUNEZ ◽  
L MAINAR ◽  
G MINANA ◽  
R ROBLES ◽  
J SANCHIS ◽  
...  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Acute Heart Failure ◽  
Preserved Ejection Fraction

Galectin-3 in Heart Failure – Linking Fibrosis, Remodelling and Progression

2010 ◽  
Vol 6 (2) ◽  
pp. 33 ◽  
Author(s):  
Christopher R deFilippi ◽  
G Michael Felker ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Risk Stratification ◽  
Cardiac Fibrosis ◽  
The Elderly ◽  
Preserved Ejection Fraction ◽  
Heart Failure Patients ◽  
Large Populations ◽  
Galectin 3

For many with heart failure, including the elderly and those with a preserved ejection fraction, both risk stratification and treatment are challenging. For these large populations and others there is increasing recognition of the role of cardiac fibrosis in the pathophysiology of heart failure. Galectin-3 is a novel biomarker of fibrosis and cardiac remodelling that represents an intriguing link between inflammation and fibrosis. In this article we review the biology of galectin-3, recent clinical research and its application in the management of heart failure patients.

Sign in / Sign up

Export Citation Format

Share Document